vorherige Seite5 of 8nächste Seite
Financial Statements
Financial Statements

Bayer Group Consolidated Statements of Cash Flows

1st Quarter 20081st Quarter 2009
 € million€ million
Income from continuing operations after taxes762424
Income taxes306215
Non-operating result275334
Income taxes paid or accrued(364)(332)
Depreciation and amortization712688
Change in pension provisions(94)(117)
(Gains) losses on retirements of noncurrent assets3(3)
Non-cash effects of the remeasurement of acquired assets
(inventory work-down)
510
Gross cash flow1,6511,209
   
Decrease (increase) in inventories(251)118
Decrease (increase) in trade accounts receivable(1,038)(672)
(Decrease) increase in trade accounts payable(196)(432)
Changes in other working capital, other non-cash items362470
   
Net cash provided by (used in) operating activities (net cash flow),
continuing operations

528

693
Net cash provided by (used in) operating activities (net cash flow),
discontinued operations

0

0
Net cash provided by (used in) operating activities (net cash flow) (total)528693
   
Cash outflows for additions to property, plant, equipment and intangible assets (288)(290)
Cash inflows from sales of property, plant, equipment and other assets1615
Cash inflows from (outflows for) divestitures(40)0
Cash inflows from (outflows for) noncurrent financial assets27137
Cash outflows for acquisitions less acquired cash(246)0
Interest and dividends received7464
Cash inflows from (outflows for) current financial assets(7)(4)
Net cash provided by (used in) investing activities (total)(464)(78)
   
Capital contributions00
Dividend payments and withholding tax on dividends(9)(4)
Issuances of debt3972,361
Retirements of debt(120)(536)
Interest paid(137)(169)
Net cash provided by (used in) financing activities (total)1311,652
   
Change in cash and cash equivalents due to business activities (total)1952,267
   
Cash and cash equivalents at beginning of period2,5312,094
   
Change in cash and cash equivalents due to changes in scope of consolidation02
Change in cash and cash equivalents due to exchange rate movements(9)2
   
Cash and cash equivalents at end of period2,7174,365
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Print page
Search
Search
Advanced Search
Download Center
 
 
 
Links
Annual Report 2008
 
Financial Reports
 
Comparison
Services
Order print version
 
Event Reminder
 
Press Newsletter
 
Would you like to be kept informed about new financial reports from Bayer?
 
SMS Service
Calendar
Investor Conference Call
 
Annual Stockholders' Meeting 2009
Info
Notes on our information package and all services